Moleculin Biotech Inc. Insider Trading
MBRX
No open-market buying or selling by insiders.
The last open-market buy by an executive or director was in Aug 2026.
Get an email when MBRX's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Aug 3 | Jonathan P. Foster Chief Financial Officer | Bought | 293,333 | — | — | 2377% | Form 4 |
| Aug 3 | Walter V Klemp CEO and President | Bought | 533,333 | — | — | 1720% | Form 4 |
| Aug 3 | Donald H Picker Chief Science Officer | Bought | 173,333 | — | — | 23019% | Form 4 |
| Jun 23, 2025 | Jonathan P. Foster Chief Financial Officer | Bought | 270,270 | $0.37 | 100K | 1561% | Form 4 |
| Jun 23, 2025 | Walter V Klemp CEO and President | Bought | 675,675 | $0.37 | 250K | 995% | Form 4 |
- Aug 3Jonathan P. FosterChief Financial Officer · bought 293,333—2377% of stake
- Aug 3Walter V KlempCEO and President · bought 533,333—1720% of stake
- Aug 3Donald H PickerChief Science Officer · bought 173,333—23019% of stake
- Jun 23, 2025Jonathan P. FosterChief Financial Officer · bought 270,270 at $0.37100K1561% of stake
- Jun 23, 2025Walter V KlempCEO and President · bought 675,675 at $0.37250K995% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with MBRX
Spot a number that looks wrong? Check it in MBRX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing MBRX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.